TPM3 and hepatocellular carcinoma: Besides, we observed that clinical stage (pTNM) and TPM3 are significantly correlated with the OS of HCC, which implied lower clinical stage and decreased TPM3 expression may be independent prognostic factors of a favorable prognosis (Figure 6B).